Kern Ralph
Worldwide Medical, Biogen, Cambridge, MA, USA.
Neurodegener Dis Manag. 2017 Feb;7(1):5-7. doi: 10.2217/nmt-2016-0061. Epub 2017 Jan 10.
Ralph Kern speaks to Laura Dormer, Commissioning Editor: Dr Ralph Kern is Senior Vice President and Head of Worldwide Medical at Biogen in Cambridge, MA, USA. In this role, he oversees Biogen's global therapeutic, regional and country medical teams, global medical operations, as well as medical research and scientific communications functions. Prior to joining Biogen, he was head of the Neuroscience Medical Unit at Novartis Pharmaceuticals Corporation and held various medical and commercial leadership roles at Genzyme Corporation. Prior to joining industry, he was a consultant neurologist at Mount Sinai Hospital and the University Health Network in Toronto, Ontario and was head of the neurology postgraduate academic program at the University of Toronto. Ralph completed neurology postgraduate training at McGill University and completed a masters of health administration from the Institute for Health Policy, Management and Evaluation at the University of Toronto. He is a member of the College of Physicians and Surgeons of Ontario and the Royal College of Physicians and Surgeons of Canada.
拉尔夫·克恩与委托编辑劳拉·多默交谈：拉尔夫·克恩博士是美国马萨诸塞州剑桥市百健公司的高级副总裁兼全球医学负责人。在这个职位上，他负责监督百健的全球治疗、区域和国家医疗团队、全球医疗运营以及医学研究和科学传播职能。在加入百健之前，他是诺华制药公司神经科学医疗部门的负责人，并在基因泰克公司担任过各种医疗和商业领导职务。在进入行业之前，他是安大略省多伦多市西奈山医院和大学健康网络的神经科顾问医生，并且是多伦多大学神经学研究生学术项目的负责人。拉尔夫在麦吉尔大学完成了神经学研究生培训，并在多伦多大学健康政策、管理与评估研究所获得了卫生管理硕士学位。他是安大略省医师和外科医生学院以及加拿大皇家内科医师和外科医生学院的成员。
